Report copyright - Year 2014-2015 Bankhead-Coley Cancer Research …...2019/04/15 · HER2+ breast cancer. However, 25% of patients with early stage HER2+ disease relapse after trastuzumab. The prognosis
Please pass captcha verification before submit form